Drug · DIN 02371022
TWYNSTA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 11, 2011; first marketed August 11, 2011.
- Drug Identification Number (DIN)
- 02371022
- Company (DIN owner)
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Telmisartan and amlodipine C09DB04
- Class
- Human
- Record last updated
- June 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TELMISARTAN | 40 MG | |
| AMLODIPINE (AMLODIPINE BESYLATE) | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 3, 2011: NOC 12529New Drug Submission (NDS)
Other DINs named TWYNSTA
- DIN 02371030 · Marketed
- DIN 02371049 · Marketed
- DIN 02371057 · Marketed